199 related articles for article (PubMed ID: 11219481)
21. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
Wilson R; Schentag JJ; Ball P; Mandell L;
Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408
[TBL] [Abstract][Full Text] [Related]
22. Performance in practice: bacteriological efficacy in patients with drug-resistant S. pneumoniae.
Garau J
Clin Microbiol Infect; 2004 Apr; 10 Suppl 2():28-35. PubMed ID: 14759231
[TBL] [Abstract][Full Text] [Related]
23. Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis.
Syrogiannopoulos GA; Bozdogan B; Grivea IN; Ednie LM; Kritikou DI; Katopodis GD; Beratis NG; Applebaum PC;
Pediatr Infect Dis J; 2004 Sep; 23(9):857-65. PubMed ID: 15361727
[TBL] [Abstract][Full Text] [Related]
24. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
Hoepelman IM; Möllers MJ; van Schie MH; Greefhorst AP; Schlösser NJ; Sinninghe Damsté EJ; van de Moosdijk CN; Dalinghaus WH; Eland ME; Mol SJ; Rozenberg-Arska M
Int J Antimicrob Agents; 1997 Jan; 9(3):141-6. PubMed ID: 9552709
[TBL] [Abstract][Full Text] [Related]
25. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
[TBL] [Abstract][Full Text] [Related]
26. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
[TBL] [Abstract][Full Text] [Related]
27. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis.
Murray JJ; Solomon E; McCluskey D; Zhang J; Palmer R; Notario G
Clin Ther; 2000 Dec; 22(12):1421-32. PubMed ID: 11192134
[TBL] [Abstract][Full Text] [Related]
28. A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia.
Gotfried MH; Dattani D; Riffer E; Devcich KJ; Busman TA; Notario GF; Palmer RN
Clin Ther; 2002 May; 24(5):736-51. PubMed ID: 12075942
[TBL] [Abstract][Full Text] [Related]
29. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
Nalepa P; Dobryniewska M; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
[TBL] [Abstract][Full Text] [Related]
30. Clarithromycin (Biaxin) extended-release tablet: a therapeutic review.
Gotfried MH
Expert Rev Anti Infect Ther; 2003 Jun; 1(1):9-20. PubMed ID: 15482099
[TBL] [Abstract][Full Text] [Related]
31. Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
Fogarty C; de Wet R; Mandell L; Chang J; Rangaraju M; Nusrat R
Chest; 2005 Oct; 128(4):1980-8. PubMed ID: 16236845
[TBL] [Abstract][Full Text] [Related]
32. Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis.
Gotfried MH; DeAbate CA; Fogarty C; Mathew CP; Sokol WN
Clin Ther; 2001 Jan; 23(1):97-107. PubMed ID: 11219483
[TBL] [Abstract][Full Text] [Related]
33. Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients.
Grossman RF; Ambrusz ME; Fisher AC; Khashab MM; Kahn JB
Clin Ther; 2006 Aug; 28(8):1175-1180. PubMed ID: 16982294
[TBL] [Abstract][Full Text] [Related]
34. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group.
Anzueto A; Niederman MS; Tillotson GS
Clin Ther; 1998; 20(5):885-900. PubMed ID: 9829441
[TBL] [Abstract][Full Text] [Related]
35. A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
Sokol WN; Sullivan JG; Acampora MD; Busman TA; Notario GF
Clin Ther; 2002 Apr; 24(4):605-15. PubMed ID: 12017405
[TBL] [Abstract][Full Text] [Related]
36. Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis.
Ziering W; McElvaine P
Infection; 1998; 26(1):68-75. PubMed ID: 9505188
[TBL] [Abstract][Full Text] [Related]
37. Cefprozil versus high-dose amoxicillin/clavulanate in children with acute otitis media.
Hedrick JA; Sher LD; Schwartz RH; Pierce P
Clin Ther; 2001 Feb; 23(2):193-204. PubMed ID: 11293553
[TBL] [Abstract][Full Text] [Related]
38. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis.
Camacho AE; Cobo R; Otte J; Spector SL; Lerner CJ; Garrison NA; Miniti A; Mydlow PK; Giguere GC; Collins JJ
Am J Med; 1992 Sep; 93(3):271-6. PubMed ID: 1524078
[TBL] [Abstract][Full Text] [Related]
39. Clinical comparison of cefuroxime axetil suspension and amoxicillin/clavulanate suspension in the treatment of pediatric patients with acute otitis media with effusion.
Gooch WM; Blair E; Puopolo A; Paster Z; Schwartz RH; Miller HC; Smyre HL; Giguere GC; Collins JJ
Clin Ther; 1995; 17(5):838-51. PubMed ID: 8595636
[TBL] [Abstract][Full Text] [Related]
40. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
